Clinician-scientist strategizes different genetic approaches to early-onset, late-onset glaucoma

WASHINGTON — In the clinician-scientist lecture at the American Glaucoma Society meeting here, Janey L. Wiggs, MD, PhD, delineated two different approaches to using genetics in glaucoma research, depending on whether the disease occurs early or late. “If you can find genes that cause glaucoma and understand what the protein products of those genes do, you can define the molecular events that are responsible for the disease,” Wiggs said. That is the first step in developing treatment targeted at the molecular events responsible for the disease, ideally treatments that could (Read more...)

Full Story →